FindTrial
Sign In

Identification and clinical validation of the causal relationship among immune cell traits and cytokines and common gynecological diseases (endometrial cancer, cervical cancer, ovarian cancer, endometriosis, etc.): a combined systematic bioinformatics analysis study based on Mendelian randomization

Identification and clinical validation of the causal relationship among immune cell traits and cytokines and common gynecological diseases (endometrial cancer, cervical cancer, ovarian cancer, endometriosis, etc.): a combined systematic bioinformatics analysis study based on Mendelian randomization

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400088899
Enrollment
Unknown
Registered
2024-08-29
Start date
2024-09-01
Completion date
Unknown
Last updated
2024-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Common gynecological diseases

Interventions

Cervical Carcinoma Case Group (Tissue samples):None
Cervical Carcinoma Control Group (Tissue samples):None
Oophoroma Case Group (Tissue samples):None
Oophoroma Control Group (Tissue samples):None
Endometriosis Case Group (Blood samples):None
Endometriosis Control Group (Blood samples):None
Endometrial Cancer Case Group (Blood samples):None
Endometrial Cancer Control Group (Blood samples):None
Cervical Carcinoma Case Group (Blood samples):None
Cervical Carcinoma Control Group (Blood samples):None
Oophoroma Case Group (Blood samples):None
Oophoroma Control Group (Blood samples):None
Endometriosis Case Group (Tissue samples):None
Endometriosis Control Group (Tissue samples):None
Endometrial Cancer Case Group (Tissue samples):None
Endometrial Cancer Control Group (Tissue samples):None

Sponsors

Hefei Maternity and Child Healthcare Hospital(Maternal and Child Health Center of Anhui Medical University)
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
30 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria for the experimental group: age 30-60 years; no other serious health problems; no relevant treatment; diagnosis of the disease Inclusion criteria for the control group: age 30-60 years; no other serious health problems; no relevant treatment; the disease was excluded

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
Expression levels of positive immune cell traits ;Positive cytokines levels;—

Countries

China

Contacts

Public ContactShu-Guang Zhou

Hefei Maternity and Child Healthcare Hospital(Maternal and Child Health Center of Anhui Medical University)

zhoushuguang@ahmu.edu.cn+86 139 5511 7688

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026